Zydus Lifesciences Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-20

Stock price
₹1149.00
Market cap
1,15,581 Cr
Stock P/E
22.6
P/B
3.91
Dividend yield
1.0%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales5,140 Cr4,369 Cr4,505 Cr5,534 Cr6,208 Cr5,237 Cr5,269 Cr6,528 Cr6,574 Cr6,123 Cr6,865 Cr7,587 Cr
Operating expenses (approx.)3,649 Cr3,223 Cr3,403 Cr3,747 Cr4,124 Cr3,776 Cr3,824 Cr4,541 Cr4,485 Cr4,142 Cr5,133 Cr5,296 Cr
EBITDA1,491 Cr1,146 Cr1,102 Cr1,787 Cr2,084 Cr1,461 Cr1,445 Cr1,987 Cr2,089 Cr1,982 Cr1,732 Cr2,291 Cr
OPM %29.0%26.2%24.5%32.3%33.6%27.9%27.4%30.4%31.8%32.4%25.2%30.2%
Other income36 Cr54 Cr38 Cr156 Cr63 Cr68 Cr58 Cr81 Cr155 Cr109 Cr111 Cr134 Cr
Interest18 Cr9 Cr20 Cr35 Cr32 Cr25 Cr32 Cr77 Cr85 Cr101 Cr130 Cr123 Cr
Depreciation180 Cr184 Cr195 Cr205 Cr215 Cr234 Cr229 Cr238 Cr238 Cr302 Cr360 Cr508 Cr
Profit before tax1,329 Cr1,007 Cr926 Cr1,547 Cr1,900 Cr1,271 Cr1,184 Cr1,672 Cr1,921 Cr1,687 Cr1,353 Cr1,660 Cr
Tax %16.3%22.5%23.1%20.8%23.0%29.4%15.2%25.3%22.6%26.9%28.7%19.2%
Net profit1,134 Cr803 Cr790 Cr1,246 Cr1,483 Cr920 Cr1,026 Cr1,244 Cr1,521 Cr1,239 Cr1,023 Cr1,341 Cr
EPS (₹)₹10.74₹7.91₹7.80₹11.69₹14.11₹9.06₹10.17₹11.64₹14.58₹12.51₹10.36₹12.65

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales13,166 Cr14,253 Cr15,102 Cr15,265 Cr17,237 Cr19,547 Cr23,242 Cr27,148 CrSign in for TTM
Operating expenses (approx.)9,991 Cr11,719 Cr11,929 Cr11,587 Cr13,982 Cr14,177 Cr16,133 Cr18,680 CrSign in for TTM
EBITDA3,174 Cr2,534 Cr3,173 Cr3,678 Cr3,256 Cr5,370 Cr7,108 Cr8,468 CrSign in for TTM
OPM %24.1%17.8%21.0%24.1%18.9%27.5%30.6%31.2%Sign in for TTM
Other income201 Cr114 Cr37 Cr225 Cr187 Cr284 Cr270 Cr510 CrSign in for TTM
Interest194 Cr342 Cr164 Cr127 Cr130 Cr81 Cr166 Cr439 CrSign in for TTM
Depreciation599 Cr697 Cr725 Cr713 Cr723 Cr764 Cr916 Cr1,408 CrSign in for TTM
Profit before tax2,382 Cr1,495 Cr2,285 Cr2,838 Cr2,590 Cr4,809 Cr6,027 Cr6,621 CrSign in for TTM
Tax %22.3%21.4%6.4%18.0%22.7%20.3%23.4%24.1%Sign in for TTM
Net profit1,899 Cr1,204 Cr2,185 Cr4,618 Cr2,092 Cr3,973 Cr4,673 Cr5,124 CrSign in for TTM
EPS (₹)₹18.06₹11.49₹20.84₹43.84₹19.30₹38.14₹44.97₹50.09Sign in for TTM
Dividend payout %———8.1%12.8%15.6%6.5%21.6%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital102 Cr102 Cr102 Cr102 Cr101 Cr101 Cr101 Cr101 Cr
Reserves10,284 Cr10,273 Cr12,890 Cr16,897 Cr17,415 Cr22,001 Cr26,258 Cr27,011 Cr
Borrowings————1,163 Cr769 Cr3,170 Cr8,582 Cr
Other liabilities—13,311 Cr10,892 Cr—4,905 Cr6,411 Cr7,674 Cr14,243 Cr
Total liabilities—23,687 Cr23,885 Cr—25,756 Cr29,281 Cr37,202 Cr52,407 Cr
Fixed assets (net)————5,697 Cr5,803 Cr6,042 Cr9,231 Cr
CWIP————1,130 Cr1,112 Cr1,318 Cr1,166 Cr
Investments————1,130 Cr804 Cr5,265 Cr6,373 Cr
Other assets————10,009 Cr11,421 Cr17,123 Cr19,910 Cr
Total assets—23,687 Cr23,885 Cr—25,756 Cr29,281 Cr37,202 Cr52,407 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———2,078 Cr2,689 Cr3,228 Cr6,777 Cr2,117 Cr
Cash from investing———1,154 Cr1,171 Cr-1,475 Cr-8,372 Cr-8,296 Cr
Cash from financing———-868 Cr-4,400 Cr-1,804 Cr2,031 Cr5,997 Cr
Net cash flow———2,373 Cr-534 Cr-75 Cr414 Cr28 Cr
Free cash flow (OCF − Capex)———876 Cr1,658 Cr2,321 Cr5,064 Cr-1,277 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %24.8%17.7%18.8%17.4%12.1%20.1%21.0%18.5%
ROE %17.8%11.3%16.4%26.4%10.0%0.5%0.6%17.0%
Debtor days————9397——
Inventory days————301274328401
Days payable————188169——
Cash conversion cycle————207202328401
Debt / equity——0.00—0.070.040.120.29
Current ratio————1.812.141.891.27
Net debt / EBITDA0.000.000.000.000.210.070.330.91

Compare with peers

Loading peers…